SCHEMBL3505353

SCHEMBL3505353

N=C(N)c1ccc(-c2ccc(-c3ccc(-c4ccc(C(=N)N)cc4)[se]3)[se]2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WDR5 P61964 1/20 0.54
▸ NQO2 P16083 4/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ PRMT1 Q99873 2/20 0.50
▸ TOP1 P11387 1/20 0.50
▸ CASP1 P29466 1/20 0.50
▸ CASP7 P55210 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ TOP2A P11388 1/20 0.48
▸ TOP2B Q02880 1/20 0.48
▸ PRSS1 P07477 2/20 0.48
▸ PRSS3 P35030 2/20 0.48
▸ PRSS2 P07478 1/20 0.48
▸ LMNA P02545 2/20 0.48
▸ PLAU P00749 2/20 0.48
▸ MASP2 O00187 1/20 0.48
▸ THPO P40225 1/20 0.48
▸ F2 P00734 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783282 0.98 WDR5 (0.56) WDR5NQO2ALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL3791148 0.96 WDR5 (0.54) WDR5NQO2ALDH1A1HPGDHSD17B10
SCHEMBL3781353 0.81 WDR5 (0.41) WDR5NQO2ALDH1A1HPGDHSD17B10
SCHEMBL3781350 0.81 PRMT1 (0.60) WDR5NQO2ALDH1A1HPGDHSD17B10
SCHEMBL8973288 0.78 WDR5 (0.80) WDR5NQO2ALDH1A1HPGDHSD17B10
SCHEMBL394218 0.78 WDR5 (0.80) WDR5NQO2ALDH1A1HPGDHSD17B10
SCHEMBL537030 0.75 LMNA (0.77) WDR5NQO2ALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL30999366 0.72 PRSS1 (0.78) WDR5ALDH1A1HPGDHSD17B10PRMT1
Hydrochloric Acid SCHEMBL392375 0.72 PRSS1 (0.78) WDR5ALDH1A1HPGDHSD17B10PRMT1
SCHEMBL3781364 0.71 PRSS1 (0.32) NQO2PRSS1PRSS3PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517893-B2 Bichalcophenes and their prodrugs as antiprotozoal agents THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-04-14 — — US claimed
EP-1726589-B1 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof UNIV NORTH CAROLINA (US) 2008-10-15 — — EP claimed
US-20060293540-A1 Novel bichalcophenes and their prodrugs as antiprotozoal agents TIDWELL RICHARD R 2006-12-28 — — US claimed
EP-1726589-A2 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2006-11-29 — — EP claimed
US-20100249175-A1 Dicationic compounds which selectively recognize G-quadruplex DNA GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2010-09-30 — — US disclosed
US-7517893-B2 Bichalcophenes and their prodrugs as antiprotozoal agents THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-04-14 — — US disclosed
EP-1726589-B1 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof UNIV NORTH CAROLINA (US) 2008-10-15 — — EP disclosed
EP-1792613-A2 Dicationic compounds which selectively recognize G-quadruplex DNA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2007-06-06 — — EP disclosed
US-20060293540-A1 Novel bichalcophenes and their prodrugs as antiprotozoal agents TIDWELL RICHARD R 2006-12-28 — — US disclosed
EP-1726589-A2 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2006-11-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249175-A1 Dicationic compounds which selectively recognize G-quadruplex DNA DDB1, DNA2, SSBP1 WDR5 1792/4885NQO2 1541/4885ALDH1A1 4594/4885
US-20060293540-A1 Novel bichalcophenes and their prodrugs as antiprotozoal agents CASP7, DDT, BAD WDR5 3551/4885NQO2 1951/4885ALDH1A1 2430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback